Rxi Pharmaceuticals Corp (NASDAQ:RXII)

3.34
Delayed Data
As of 3:59pm ET
 -0.09 / -2.62%
Today’s Change
2.91
Today|||52-Week Range
11.20
-39.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues399.0K71.0K34.0K19.0K
 
 
 
 
 
Depreciation And Amortization99.0K87.0K77.0K53.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses21.2M8.8M10.2M9.0M
 
 
 
 
 
Research And Development17.7M5.7M6.9M5.4M
 
 
 
 
 
Total Operating Expenses21.3M8.9M10.3M9.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.9M-8.8M-10.2M-9.0M
 
 
 
 
 
Other Expenses0.009.0K-2.0K6.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.9M-8.8M-10.2M-9.0M
 
 
 
 
 
Preferred Dividend-8.6M-4.1M-209.0K-2.1M
 
 
 
 
 
Net Income-20.9M-8.8M-10.2M-9.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS102.6K163.6K497.0K674.6K
 
 
 
 
 
Shares To Calculate EPS Diluted102.6K163.6K497.0K674.6K
 
 
 
 
 
 
Earnings Per ShareEPS-$288.00-$79.00-$21.00-$16.40
 
 
 
 
 
EPS Diluted-$288.00-$79.00-$21.00-$16.40